D (2 End)
Dapsone 6% / Niacinamide 2% / Spironolactone 5%
Product Images NDC 72934-1061
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 6% / Niacinamide 2% / Spironolactone 5% (NDC 72934-1061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Sf (1061 2 Front)
This appears to be a label for a medication, specifically a topical gel containing 6% dapsone, 2% niacinamide, and 5% spironolactone. The label also provides information on the size of the container (30 grams) and the National Drug Code (NDC) for the medication (72934-1061-2). The remaining text is illegible or appears to be an error in the process.*
S (1061 2 Middle)
This appears to be a medication prescription with the lot number O11503ABCDERGHE@, with an expiration date of 01/01/1970. The medication contains active ingredients such as Dapsone, Niacinamide, and Spironolactone. The inactive ingredients include Butylated Hydroxytoluene, Lavender Oil, Propylene Glycol, and Suspendisse Gel.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
